Emerging in the field of obesity management, retatrutide is a different approach. Unlike many available medications, retatrutide operates as a twin agonist, simultaneously targeting both GLP peptide-1 (GLP-1) and https://katrinazzjq993481.aboutyoublog.com/47132439/the-novel-retatrutide-a-glp-gip-receptor-agonist